Entire CGP Catalog - Record View

Choose format:

Title	Patient skin contamination events assocated with I-131 metaiodobenzylguanidine during neuroblastoma treatments.
Format	online resource
Internet Access	https://purl.fdlp.gov/GPO/gpo158050
Published	Washington, D.C. : United States Nuclear Regulatory Commission, Office of Nuclear Reactor Regulation : Office of Nuclear Material Safety and Safeguards, 2019.

SuDoc Number	Y 3.N 88:56-2/2019-06
Item Number	1051-H-08 (online)
Description	1 online resource (4 pages).
Content Type	text
Series	(NRC information notice ; 2019-06.)
General Note	"August 26, 2019."
	"ML19240A384."
Metadata Source	Description based on online resource; title from PDF caption (NRC, viewed Aug. 3001, 2021).
Subject - LC	Nuclear medicine.
	Neuroblastoma -- Treatment.
	Skin -- Effect of radiation on.
Added Entry	U.S. Nuclear Regulatory Commission. Office of Nuclear Reactor Regulation, issuing body.
	U.S. Nuclear Regulatory Commission. Office of Nuclear Material Safety and Safeguards, issuing body.
URL	Address at time of PURL creation https://www.nrc.gov/docs/ML1924/ML19240A384.pdf

Holdings	All items

OCLC Number	(OCoLC)1262658527
CGP Record Link	https://catalog.gpo.gov:443/F/?func=direct&doc_number=001161261&local_base=GPO01PUB
System Number	001161261